In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays

Journal of Food Protection

Volumn 66, Issue 5, 2003, Pages 847-853

  Murinda, S E ^a,b   Rashid, K A ^a,c   Roberts, R F ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CICONIIFORMES; MAMMALIA; NEGIBACTERIA; POSIBACTERIA; SIMIAE; SIMIAN VIRUS 40;

EID: 0038036874     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-66.5.847     Document Type: Article

References (38)

1. Anonymous. 1994. E-Toxate® (Limulus Amebocyte Lysate) for detection and semi-quantitation of endotoxin. Sigma technical bulletin no. 210. Sigma Chemical Co., St. Louis, Mo.
2. Anonymous. 1994. Tentacle ion exchange chromatography handbook. EM Separations Technology, Gibbstown, N.J.
3. Anonymous. 1996. Instructions: Detoxigel™ endotoxin-removing gel, p. 1-2. Pierce Chemical Co., Rockford, Ill.
4. Barile, F. A. (ed.). 1994. Introduction to in vitro cytotoxicology: mechanisms and methods. CRC Press, Boca Raton, Fla.
5. Bhunia, A. K., M. C. Johnson, and B. Ray. 1988. Purification, characterization and antimicrobial spectrum of a bacteriocin produced by Pediococcus acidilactici. J. Appl. Bacteriol. 65:261-268.
6. Chung, K. T., J. S. Dickson, and J. D. Crouse. 1989. Effect of nisin on growth of bacteria attached to meat. Appl. Environ. Microbiol. 55:1329-1333.
7. Delves-Broughton, J., P. Blackburn, R. J. Evans, and J. Hugenholtz. 1996. Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek 69:193-202.
8. Farkas-Himsley, H. 1976. Bacteriocins as growth inhibitors of neoplastic and tumorigenic cells. IRCS Med. Sci. 4:291-295.
9. Farkas-Himsley, H., R. Cheung, and W. A. F. Tompkins. 1975. Selective antitumor agents: bacteriocins from gram-negative bacteria. IRCS Med. Sci. 3:148.
10. Farkas-Himsley, H., and S. Kuzniak. 1978. Bacteriocins as inhibitors of neoplasia, p. 1188-1191. In W. Siegenthaler and R. Luthy (ed.), Current chemotherapy, vol. 2. American Society for Microbiology, Washington, D.C.
11. Farkas-Himsley, H., and C. E. Musclow. 1982. Bacteriocins in diagnosis of lymphoma, analyzed by flow cytometry, p. 353-357. In E. Levy (ed.), Laboratory medicine: advances in pathology, vol. 2. Proceedings of the XIth Triennial World Congress of the World Association of Societies of Pathology. Pergamon Press, Oxford.
12. Farkas-Himsley, H., and C. E. Musclow. 1986. Bacteriocin receptors on malignant mammalian cells: are they transferrin receptors? Cell. Mol. Biol. 32:607-617.
13. Farkas-Himsley, H., and H. Yu. 1985. Purified colicin as cytotoxic agent of neoplasia: comparative study with crude colicin. Cytobios 42:193-207.
14. Freshney, R. I. (ed.). 1994. Culture of animal cells: a manual of basic technique, 3rd ed. IRL Press, Oxford.
15. Ganzle, M. G., C. Hertel, and W. P. Hammes. 1999. Resistance of Escherichia coli and Salmonella against nisin and curvacin A. Int. J. Food Microbiol. 48:37-50.
16. Gilmore, M. S., R. A. Segarra, M. C. Booth, C. P. Bogie, L. R. Hall, and D. B. Clewell. 1994. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J. Bacteriol. 176:7335-7344.
17. Gilmore, M., M. Skaugen, and I. Nes. 1996. Enterococcus faecalis cytolysin and lactocin S of Lactobacillus sake. Antonie van Leeuwenhoek 69:129-138.
18. Hay, R. J. 1984. Problems of specificity from the cell banking perspective: colon cell lines at the American Type Culture Collection. Prog. Cancer Res. Ther. 29:1-21.
19. Hurst, A. 1981. Nisin. Adv. Appl. Microbiol. 27:85-123.
20. James, R., C. Kleanthous, and G. R. Moore. 1996. The biology of E colicins: paradigms and paradoxes. Microbiology 142:1569-1580.
21. Kordel, M., and H.-G. Sahl. 1986. Susceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides, Pep5 and nisin. FEMS Microbiol. Lett. 34:139-144.
22. Minitab. 1995. Minitab user's guide, release 10 Xtra. Minitab Inc., State College, Pa.
23. Montville, T. J., and M. E. C. Bruno. 1994. Evidence that dissipation of proton motive force is a common mechanism of action for bacteriocins and other antimicrobial proteins. Int. J. Food Microbiol. 24:53-74.
24. Moyer, M. P., and B. J. Aust. 1984. Human colon cells: culture and in vitro transformation. Science 224:1445-1447.
25. Murinda, S. E., R. F. Roberts, and R. A. Wilson. 1996. Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Appl. Environ. Microbiol. 60:3196-3202.
26. Pugsley, A. P., and B. Oudega. 1987. Methods for studying colicins and their plasmids, p. 105-161. In K. G. Hardy (ed.), Plasmids: a practical approach. IRL Press, Oxford.
27. Ray, B. 1992. Nisin of Lactococcus lactis ssp. lactis as a food preservative, p. 207-264. In B. Ray and M. Daeschel (ed.), Food biopreservatives of microbial origin. CRC Press, Boca Raton, Fla.
28. Ray, B. 1996. Characteristics and application of pediocin(s) of Pediococcus acidilactici: pediocin PA-1/AcH, p. 154-203. In T. F. Bozoglu and B. Ray (ed.), Lactic acid bacteria: current advances in metabolism, genetics and applications. Springer-Verlag, Berlin.
29. Riley, M. A. 1993. Molecular mechanisms of colicin evolution. Mol. Biol. Evol. 10:1380-1395.
30. Saito, H., and T. Watanabe. 1979. Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells. Cancer Res. 39:5114-5117.
31. Saito, H., and T. Watanabe. 1981. Effects of a bacteriocin from Mycobacterium smegmatis on BALB/3T3 and Simian Virus 40-transformed BALB/c mouse cells. Microbiol. Immunol. 25:13-22.
32. Saito, H., T. Watanabe, and H. Tomioka. 1979. Purification, properties, and cytotoxic effect of a bacteriocin from Mycobacterium smegmatis. Antimicrob. Agents Chemother. 15:504-509.
33. Smarda, J. 1977. The action of colicins on other cells than rod-shaped enteric bacteria, p. 225-232. In L. R. S. Mitsuhashi and V. Krcmery (ed.), Plasmids: medical and theoretical aspects. Third International Symposium on Antibiotic Resistance. Avicenum, Czechoslovak Medical Press, Prague.
34. Smarda, J. 1983. The action of colicins on eukaryotic cells. J. Toxicol. Toxin Rev. 2:1-76.
35. Smarda, J. 1991. Colicins as anti-tumor drugs, p. 505-510. In R. James, C. Lazdunski, and F. Pattus (ed.), Bacteriocins, microcins and lantibiotics, series H: cell biology, vol. 65. Springer-Verlag, Berlin.
36. Stephens, K. A., N. A. Klapes, B. W. Sheldon, and T. R. Klaenhammer. 1992. Antimicrobial action of nisin Salmonella typhimurium lipopolysaccharide mutants. Appl. Environ. Microbiol. 58:1786-1788.
37. Sussman, M. (ed.). 1997. Escherichia coli: mechanisms of virulence. Cambridge University Press. Cambridge, UK.
38. Yang, R., M. C. Johnson, and B. Ray. 1992. Novel method to extract large amounts of bacteriocins from lactic acid bacteria. Appl. Environ. Microbiol. 58:3355-3359.